Clinical trial Recruiting at 1 site Interventional Ages 45 to 80

Shock Waves for Knee Osteoarthritis

Official title: Extracorporeal Shock Wave Therapy in Patients With Knee Arthritis

Run by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · NCT06833372 · Data updated 2026-11-12

This study tests whether shock wave therapy plus home exercise helps people with knee osteoarthritis more than exercise alone.

Quick facts

Study typeInterventional
Ages45 Years to 80 Years
SexAll
Enrollment72 (estimated)
SponsorAzienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Academic / other
Locations1 site (Bari)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedMarch 1, 2027
Study endsSeptember 1, 2027
Registry record updatedOctober 30, 2026
Trial IDNCT06833372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with persistent knee pain for at least 3 months and radiographic knee OA grade 2–3 who can participate in the therapy programs.

Probably not a fit

Individuals with inability to walk, spinal or hip sources of knee pain, or other conditions that limit participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates the effects of extracorporeal shock wave therapy (ESWT) on pain and function in adults with knee osteoarthritis. Participants are assigned to an ESWT group or an exercise-only group to compare outcomes. The treatment targets symptomatic knee OA with grade 2–3 Kellgren-Lawrence changes, and includes follow-up for pain, function, and tissue-level changes. Eligibility requires chronic knee pain, radiographic OA, and ability to participate in the prescribed therapies. The study aims to determine if ESWT provides additional benefit beyond a structured exercise program.

Why it matters

Potential benefit: If successful, ESWT could provide added pain relief and improved knee function for people with knee osteoarthritis.

How similar studies have gone: Early clinical experiences suggest ESWT may help in arthritis models, but evidence in knee OA is emergent and exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* persistent knee pain for at least 3 months, measured with a VAS scale of 4 or higher,
* clinical and radiological diagnosis confirming knee osteoarthritis grade 2 and 3 based on the Kellgren-Lawrence system,
* no history of physical therapy in the last 3 months,
* no infections, tumors in the treatment area of the knee,
* no pathology other than osteoarthritis that could cause knee pain,
* no pathology of the lumbar spine or hip that could refer knee pain,
* free from any condition that prevents participation in exercise or physical therapy willing to participate regularly in the treatment programs were included in the study.

Exclusion Criteria:

* inability to walk,
* a history of clinically symptomatic spinal stenosis or lumbar radiculopathy,
* evidence of a neurological disorder based on history or physical examination,
* generalized pain or fibromyalgia,
* secondary osteoarthritis (to metabolic or rheumatologic disease),
* administration of intra-articular injections (anesthetic, hyaluronic acid, cortisone) of the knee in the last 6 months,
* use of NSAIDs, paracetamol or topical agents in the previous week,
* a previous history of surgery involving the knee joint,
* contraindications to physical therapy (PM, epilepsy, neoplasia, coagulopathy, pregnancy).

Where it's running

  • Policlinico di Bari
    Bari, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.